Product Information
CARISOPRODOL 350 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0706 per EA under NDC 16571078101. Its NADAC has been published 264 times since Sep 15, 2021.
FDA first approved this application on Aug 6, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
350 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571078101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARISOPRODOLApproval Type
Generic (ANDA)
FDA Application
ANDA040792FDA Approved
8/6/2009
TE Code
AB
On Market Since
8/6/2009
Pharmacological Classes
Price Statistics
The NADAC for CARISOPRODOL 350 MG TABLET has been published 264 times since Sep 15, 2021, and over the history we have for it it has risen 7.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0706 per EA |
|---|---|
| All-time high | $0.0820 (Oct 16, 2024) |
| All-time low | $0.0475 (Mar 22, 2023) |
| 52-week high | $0.0706 |
| 52-week low | $0.0657 |
| Median price | $0.0655 |
| Average price | $0.0633 |
| Largest weekly change | +33.1% (Jun 19, 2024) |
| Weeks tracked | 264 |
| Tracking since | Sep 15, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
carisoprodol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARISOPRODOL 350 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARISOPRODOL 350 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0706 per EA (NDC 16571078101), effective Sep 30, 2026.
How has the price of CARISOPRODOL 350 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARISOPRODOL 350 MG TABLET has risen 7.9%. It has been tracked across 264 weekly CMS publications since Sep 15, 2021.
What are the highest and lowest recorded NADAC prices for CARISOPRODOL 350 MG TABLET?
Since Sep 15, 2021, the NADAC for CARISOPRODOL 350 MG TABLET has ranged from a low of $0.0475 (Mar 22, 2023) to a high of $0.0820 (Oct 16, 2024), with a median of $0.0655 per EA.
Are there cheaper alternatives to CARISOPRODOL 350 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARISOPRODOL 350 MG TABLET, is $0.0679 per EA — about 4% below CARISOPRODOL 350 MG TABLET.
Who manufactures CARISOPRODOL 350 MG TABLET?
CARISOPRODOL 350 MG TABLET (NDC 16571078101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.